SYTE.bio is a cutting- edge preclinical stage synthetic biology company focused on the discovery and development of precision synthetic DNA & RNA-based therapeutics. The company has developed two proprietary and IP-protected platforms: Linear DNA and Circular RNA, and is now starting development of innovative and disruptive oncology immunotherapies, gene therapies for rare genetic disorders and vaccines, and therapie to potentially bringing several future breakthroughs worldwide.